Source: Biospectrum Asia

Aculys: Aculys Pharma, SUSMED to conduct world's first clinical trial using blockchain

Aculys Pharma and SUSMED to conduct the world's first clinical trial utilizing blockchain technology

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Hidemasa Tanigaki's photo - CEO of Aculys

CEO

Hidemasa Tanigaki

CEO Approval Rating

90/100

Read more